Terms: = Ovarian cancer AND CEACAM5, CEA AND Prognosis
74 results:
1. Preoperative serum CA125 level is a good prognostic predictor in patients with intrahepatic cholangiocarcinoma after hepatectomy: A single-center retrospective study.
Meng J; Weng J; Wu J; Mao H; Huang P; Chen S; Liu L
Medicine (Baltimore); 2023 Sep; 102(36):e34839. PubMed ID: 37682202
[TBL] [Abstract] [Full Text] [Related]
2. ovarian seromucinous carcinoma: an independent epithelial ovarian cancer?
Hu Y; Fu K; Liu H; He Q; Qiu X; Yang W; Zhang Y
J Ovarian Res; 2023 Jan; 16(1):18. PubMed ID: 36670456
[TBL] [Abstract] [Full Text] [Related]
3. Primary leiomyosarcoma of ovary: A rare malignancy as an incidental finding.
Raychaudhuri S; Sidam D; Jain M; Chawla R; Pujani M; Wadhwa R
Indian J Pathol Microbiol; 2022; 65(4):938-941. PubMed ID: 36308213
[TBL] [Abstract] [Full Text] [Related]
4. Membranous and nuclear staining of CLDN18 in HPV-independent and HPV-associated endocervical adenocarcinomas.
Du X; Hu Y; Ji X; Sui L; Zheng Q; Song K; Lv T; Chen Y; Zhao H; Dai S; Zhao P; Yao Q
Cancer Med; 2023 Jan; 12(2):1441-1450. PubMed ID: 35861118
[TBL] [Abstract] [Full Text] [Related]
5. Moderately differentiated Sertoli-Leydig cell tumor of ovary with associated mucinous carcinoma and carcinoid-A case report and review of literature.
Ravichandaran A; Lakshmanan A; Kurian A; Prasad S
Indian J Pathol Microbiol; 2021; 64(3):528-531. PubMed ID: 34341265
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic factors for ovarian metastases in colorectal cancer patients.
Chen C; Wang D; Ge X; Wang J; Huang Y; Ling T; Jin T; Yang J; Wang F; Wu W; Sun L
World J Surg Oncol; 2021 Jul; 19(1):220. PubMed ID: 34284773
[TBL] [Abstract] [Full Text] [Related]
7. Preoperative Differentiation of Benign and Malignant Non-epithelial ovarian Tumors: Clinical Features and Tumor Markers.
Gomes TA; Campos EA; Yoshida A; Sarian LO; Andrade LALA; Derchain SF
Rev Bras Ginecol Obstet; 2020 Sep; 42(9):555-561. PubMed ID: 32992358
[TBL] [Abstract] [Full Text] [Related]
8. Prognostic significance of elevated pretreatment serum levels of cea and CA-125 in epithelial ovarian cancer.
Lin YH; Wu CH; Fu HC; Chen YJ; Chen YY; Ou YC; Lin H
Cancer Biomark; 2020; 28(3):285-292. PubMed ID: 32390605
[TBL] [Abstract] [Full Text] [Related]
9. Gynecologic cancer in pregnancy.
Korenaga TK; Tewari KS
Gynecol Oncol; 2020 Jun; 157(3):799-809. PubMed ID: 32268951
[TBL] [Abstract] [Full Text] [Related]
10. [Appendix cancer with Long-Term Survival after Multimodality Therapy-A Case Report].
Kitagawa D; Hu Q; Takada K; Hasegawa H; Kishihara F; Funahashi S; Kitamura M
Gan To Kagaku Ryoho; 2019 Dec; 46(13):2560-2561. PubMed ID: 32156998
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic factors in Krukenberg tumor.
Lionetti R; De Luca M; Travaglino A; Raffone A; Saccone G; Di Cicco A; Insabato L; Mascolo M; D'Armiento M; Zullo F; Corcione F
Arch Gynecol Obstet; 2019 Nov; 300(5):1155-1165. PubMed ID: 31542818
[TBL] [Abstract] [Full Text] [Related]
12. Higher expression of calcineurin predicts poor prognosis in unique subtype of ovarian cancer.
Xin B; Ji KQ; Liu YS; Zhao XD
J Ovarian Res; 2019 Aug; 12(1):75. PubMed ID: 31399054
[TBL] [Abstract] [Full Text] [Related]
13. PELP1 is a novel oncogene in gastric tumorigenesis and negatively regulated by miR-15 family microRNAs.
Ma C; Miao C; Wang C; Song F; Luo M
Cancer Biomark; 2019; 26(1):1-9. PubMed ID: 31322541
[TBL] [Abstract] [Full Text] [Related]
14. Effects of metastasectomy and other factors on survival of patients with ovarian metastases from gastric cancer: a systematic review and meta-analysis.
Zhang C; Hou W; Huang J; Yin S; Wang P; Zhang Z; Tan Y; Xu H
J Cell Biochem; 2019 Sep; 120(9):14486-14498. PubMed ID: 31050365
[TBL] [Abstract] [Full Text] [Related]
15. [Genital metastases from breast cancer: study of 3 cases and literature review].
Zoukar O; Haddad A; Daldoul A; Zaied S; Salem AB; Zouari I; Faleh R
Pan Afr Med J; 2018; 30():7. PubMed ID: 30123410
[TBL] [Abstract] [Full Text] [Related]
16. Expression and Targeting of Tumor Markers in Gelfoam
Hoffman RM; Guadagni F
Methods Mol Biol; 2018; 1760():29-37. PubMed ID: 29572791
[TBL] [Abstract] [Full Text] [Related]
17. Elevated Serum Level of CA125 Is a Biomarker That Can Be Used to Alter prognosis Determined by BRCA Mutation and Family History in ovarian cancer.
Liu W; Wang Z; Ma J; Hou Y; Zhao J; Dong B; Tu S; Wang L; Guo Y
Genet Test Mol Biomarkers; 2017 Sep; 21(9):547-554. PubMed ID: 28799806
[TBL] [Abstract] [Full Text] [Related]
18. Identification of factors that impact recurrence in patients with borderline ovarian tumors.
Chen X; Fang C; Zhu T; Zhang P; Yu A; Wang S
J Ovarian Res; 2017 Apr; 10(1):23. PubMed ID: 28376898
[TBL] [Abstract] [Full Text] [Related]
19. Difficulty in diagnosis and different prognoses between colorectal cancer with ovarian metastasis and advanced ovarian cancer: An empirical study of different surgical adoptions.
Lee KC; Lin H; ChangChien CC; Fu HC; Tsai CC; Wu CH; Ou YC
Taiwan J Obstet Gynecol; 2017 Feb; 56(1):62-67. PubMed ID: 28254228
[TBL] [Abstract] [Full Text] [Related]
20. [Long-Term Survival in Response to Multimodality Therapy in a Patient with Invasive Pancreatic cancer with Cyst Formation].
Makino H; Kametaka H; Fukada T; Seike K; Hasegawa A; Isozaki M
Gan To Kagaku Ryoho; 2016 Nov; 43(12):1997-1999. PubMed ID: 28133201
[TBL] [Abstract] [Full Text] [Related]
[Next]
